4D Molecular Therapeutics, Inc. (FDMT)
14.67
-0.24
(-1.61%)
USD |
NASDAQ |
Aug 28, 16:00
14.66
-0.01
(-0.07%)
After-Hours: 20:00
4D Molecular Therapeutics Total Assets (Quarterly) : 492.62M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 492.62M |
| March 31, 2026 | 512.90M |
| December 31, 2025 | 566.71M |
| September 30, 2025 | 423.98M |
| June 30, 2025 | 473.64M |
| March 31, 2025 | 515.73M |
| December 31, 2024 | 560.38M |
| September 30, 2024 | 604.03M |
| June 30, 2024 | 620.12M |
| March 31, 2024 | 629.88M |
| December 31, 2023 | |
| September 30, 2023 | 361.61M |
| June 30, 2023 | 352.50M |
| March 31, 2023 | 244.02M |
| Date | Value |
|---|---|
| December 31, 2022 | 261.85M |
| September 30, 2022 | 280.16M |
| June 30, 2022 | 302.94M |
| March 31, 2022 | 324.93M |
| December 31, 2021 | 353.49M |
| September 30, 2021 | 240.62M |
| June 30, 2021 | 254.93M |
| March 31, 2021 | 270.11M |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 58.23M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amgen, Inc. | 95.64B |
| AnaptysBio, Inc. | 329.68M |
| Precision BioSciences, Inc. | 125.92M |
| Design Therapeutics, Inc. | 215.13M |
| Inhibrx Biosciences, Inc. | 154.22M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 84.96M |
| Shareholders Equity (Quarterly) | 407.66M |
| Debt to Equity Ratio | 0.0962 |
| Current Ratio | 8.033 |
| Net Debt Paydown Yield | -0.42% |